Matthew Korenberg
2015
In 2015, Matthew Korenberg earned a total compensation of $2.8M as Vice President, Finance and Chief Financial Officer at Ligand Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $56,269 |
|---|---|
| Option Awards | $1,340,490 |
| Salary | $140,673 |
| Stock Awards | $1,255,080 |
| Other | $5,464 |
| Total | $2,797,976 |
Korenberg received $1.3M in option awards, accounting for 48% of the total pay in 2015.
Korenberg also received $56.3K in non-equity incentive plan, $140.7K in salary, $1.3M in stock awards and $5.5K in other compensation.
Rankings
In 2015, Matthew Korenberg's compensation ranked 3,414th out of 13,638 executives tracked by ExecPay. In other words, Korenberg earned more than 75.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,414 out of 13,638 | 75th |
Division Manufacturing | 1,238 out of 5,187 | 76th |
Major group Chemicals And Allied Products | 449 out of 1,857 | 76th |
Industry group Drugs | 358 out of 1,531 | 77th |
Industry Pharmaceutical Preparations | 285 out of 1,179 | 76th |
Source: SEC filing on April 14, 2017.
Korenberg's colleagues
We found five more compensation records of executives who worked with Matthew Korenberg at Ligand Pharmaceuticals in 2015.
2015
John Higgins
Ligand Pharmaceuticals
Chief Executive Officer
2015
Matthew Foehr
Ligand Pharmaceuticals
Chief Operating Officer
2015
Nishan de Silva
Ligand Pharmaceuticals
Chief Financial Officer
2015
Charles Berkman
Ligand Pharmaceuticals
General Counsel
2015
Melanie Herman
Ligand Pharmaceuticals